Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Beijing Friendship Hospital
Beijing Friendship Hospital
NGM Biopharmaceuticals, Inc
Centre Hospitalier Universitaire Vaudois
Universitair Ziekenhuis Brussel
Kaiser Permanente
University Medical Center Groningen
Massachusetts General Hospital
Immix Biopharma, Inc.
Kineta Inc.
Namida Lab
Shanghai Yunying Medical Technology
Ankara Yildirim Beyazıt University
Assistance Publique - Hôpitaux de Paris
MiRXES Pte Ltd
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Impact Therapeutics, Inc.
China Medical University Hospital
Regina Elena Cancer Institute
Charite University, Berlin, Germany
Blue Note Therapeutics
Main Line Health
Imperial College London
Silverback Therapeutics
Assistance Publique - Hôpitaux de Paris
Istanbul Saglik Bilimleri University
Weprom
Shenzhen Kangzhe Pharmaceutical Co., Ltd.
Shanghai Fengxian District Central Hospital
Jerome Canady Research Institute for Advanced Biological & Technological Sciences
University Hospital Southampton NHS Foundation Trust
SpeciCare
Medical University Innsbruck
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Aalborg University
Petra Pharma
Samyang Biopharmaceuticals Corporation
Instituto do Cancer do Estado de São Paulo
The University of The West Indies
Placon Therapeutics
Xuanwu Hospital, Beijing
Quantgene Inc.
University Hospital, Strasbourg, France
Institut National de la Santé Et de la Recherche Médicale, France
Poveda, Andrés, M.D.
Heidelberg University
SPGO Research Mannheim GmbH
Rigshospitalet, Denmark
Shenzhen Second People's Hospital
Women's College Hospital
Arno Therapeutics